Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

mdpi.com
mdpi.com > 2076-16/16/3417 > 8159

Applied Sciences, Vol. 16, Pages 8159: Lycopene Nanoencapsulation and Cancer Treatment: A Systematic Review of Preclinical Evidence

3+ hour, 53+ min ago   (507+ words) Lycopene is a natural compound with significant antitumor potential, although its poor bioavailability restricts its clinical application. To address this limitation, diverse nanoparticle-based delivery systems have been developed. This systematic review evaluated whether encapsulation improves the antitumoral efficacy of lycopene....

scitechdaily.com
scitechdaily.com > scientists-may-have-solved-a-long-standing-melanoma-treatment-mystery

Scientists May Have Solved a Long-Standing Melanoma Treatment Mystery

21+ hour, 5+ min ago   (655+ words) With cancer treatment, when a drug is given may matter almost as much as which drug is used. For years, melanoma researchers have faced a frustrating contradiction. Experiments suggested that periodically stopping certain targeted drugs might help keep resistant cancer…...

NewsBreak
newsbreak.com > iowa-capital-dispatch-563743 > 4829817286095-iowa-cancer-researchers-focus-on-white-blood-cell-maturation-resiliency

Iowa cancer researchers focus on white blood cell maturation, resiliency

1+ day, 11+ hour ago   (738+ words) Researchers at Iowa’s public and private universities are focusing their efforts on white blood cells as they explore potential new cancer treatments. Iowa State University and Des Moines University faculty have published research on the growth and internal operations of…...

Technology Org
technology.org > 08/15/2026 > finding-what-it-takes-to-make-a-white-blood-cell-could-lead-to-new-cancer-treatment

Finding what it takes to make a white blood cell could lead to new cancer treatment

1+ day, 8+ hour ago   (635+ words) In leukemia’s most aggressive forms, the blood cell factories in our bone marrow falter. Instead of dividing and multiplying at their usual prolific pace, generating hundreds of billions of new cells daily, some precursor cells stall out at an immature…...

Nature
nature.com > articles > s41590-026-02629-w

Immune imprinting in a changing world - Nature Immunology

1+ day, 20+ hour ago   (192+ words) Nature Immunology (2026) Cite this article Research on SARS-CoV-2 shows that effective immunity can arise from a balance between recalling existing immune memory and generating new variant-specific antibodies, with important implications for designing future vaccines. Koutsakos, M. & Ellebedy, A. H. Immunity 56, 909–913 (2023). Cobey, S. Nat....

Nature
nature.com > articles > s41586-026-11023-3

Author Correction: Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP

1+ day, 20+ hour ago   (0+ words) ...

AllSci
allsci.com > news > approvals > felzartamab-approval-china-wins-first-global-for

Biogen's felzartamab wins first global approval in China for multiple myeloma

2+ day, 25+ min ago   (137+ words) TJ Biopharma led clinical development and the NMPA registration filing in Greater China. Under a deal struck in April 2026, Biogen acquired exclusive Greater China commercialization rights for felzartamab, consolidating global rights to the asset. Biogen will handle commercial launch; TJ…...

BioPharma Dive
biopharmadive.com > news > bristol-myers-zenbexus-fda-multiple-myeloma-celmod-celgene > 827912

Bristol Myers wins ‘milestone’ FDA approval of myeloma drug acquired from Celgene

1+ day, 21+ hour ago   (242+ words) The clearance of Zenbexus is the first for a group of protein-degrading “CELMoD” medicines that could help Bristol Myers rejuvenate a key drug franchise. Bristol Myers won its latest approval based on Phase 3 data showing the Zenbexus combination was superior…...

AllSci
allsci.com > news > regulatory > lyme-disease-vaccine-ema-begins-review-of

Pfizer, Valneva Lyme vaccine enters EU review after Phase III

2+ day, 3+ hour ago   (73+ words) Pfizer holds exclusive manufacturing and commercialization rights under a collaboration agreement with Valneva first signed in April 2020 and restructured in June 2022, under which Valneva is eligible to receive milestones and tiered royalties on net sales. Access the AllSci platform to…...

RAPPLER
rappler.com > technology > features > 256275-medical-apps-coronavirus-philippines-sinat-eddie-fightcovid

3 Filipino-made medical apps to help combat coronavirus

2+ day, 7+ hour ago   (608+ words) MANILA, Philippines – A self-assessment survey to determine who needs proper testing, an emergency dispatcher app, and an improvised thermal scanner – these are just some of the innovative and cost-efficient tech solutions shared by local developers to help fight the spread…...